141 related articles for article (PubMed ID: 3083994)
21. Measles immune globulin. Proposed standard dose given with liver attenuated measles virus vaccine.
Warren RJ; Nader PR; Levine RH
JAMA; 1968 Jan; 203(3):186-8. PubMed ID: 4169348
[No Abstract] [Full Text] [Related]
22. Immunization against measles in children at risk for severe disease.
Wesley A; Coovadia HM; Watson AR
Trans R Soc Trop Med Hyg; 1979; 73(6):710-5. PubMed ID: 120046
[TBL] [Abstract][Full Text] [Related]
23. Effectiveness of mumps virus given alone or in combination with live vaccines against measles and rubella.
Nasibov MN; Yakovleva NV; Smorodintsev AA
Prog Immunobiol Stand; 1970; 4():676-82. PubMed ID: 5482205
[No Abstract] [Full Text] [Related]
24. [The national vaccination program against measles].
Cohen H; Brouwer R; Bijkerk H; Phaff JM
Ned Tijdschr Geneeskd; 1978 Jan; 122(2):46-51. PubMed ID: 619292
[No Abstract] [Full Text] [Related]
25. Comparative studies of measles vaccines in a controlled trial in the USSR.
Bolotovskij VM; Nefedova LA; Gelikman BG; Zargaryants AT; Zetilova LP; Nastasina KT
Bull World Health Organ; 1966; 34(6):859-64. PubMed ID: 5296534
[TBL] [Abstract][Full Text] [Related]
26. [Comparative studies of measles vaccines prepared from further attenuated strains Schwarz and SEVAC].
Adam E; Fosenbauerová E; Domorázková E; Kratochvílová M; Kubátová E; Mares I; Drevo M; Svandová E
Cesk Pediatr; 1968 Jul; 23(7):581-93. PubMed ID: 5681931
[No Abstract] [Full Text] [Related]
27. Measles vaccines used in Japan.
Hirayama M
Rev Infect Dis; 1983; 5(3):495-503. PubMed ID: 6879005
[TBL] [Abstract][Full Text] [Related]
28. Clinical, antigenic and prophylactic effects of an inactivated measles virus vaccine.
Kapikian AZ; Bell JA; James RG; Holbrook Z
Am J Epidemiol; 1966 Jul; 84(1):138-49. PubMed ID: 5944729
[No Abstract] [Full Text] [Related]
29. Duration of immunity following immunization with live measles vaccine: 15 years of observation in Zhejiang Province, China.
Dai B; Chen ZH; Liu QC; Wu T; Guo CY; Wang XZ; Fang HH; Xiang YZ
Bull World Health Organ; 1991; 69(4):415-23. PubMed ID: 1934235
[TBL] [Abstract][Full Text] [Related]
30. [Measles vaccination].
Enders G
Zentralbl Bakteriol Orig A; 1972 May; 220(1):273-83. PubMed ID: 4145578
[No Abstract] [Full Text] [Related]
31. Edmonston B and a further attenuated measles vaccine--a placebo controlled double blind comparison.
Miller G; Gale J; Villarejos V; James W; Arteaga CG; Casey H; Henderson DA
Am J Public Health Nations Health; 1967 Aug; 57(8):1333-40. PubMed ID: 4860064
[No Abstract] [Full Text] [Related]
32. WHO-supported comparative studies of attenuated live measles virus vaccines.
Cockburn WC; Pecenka J; Sundaresan T
Bull World Health Organ; 1966; 34(2):223-31. PubMed ID: 4161187
[TBL] [Abstract][Full Text] [Related]
33. A study of the protective effect of live measles vaccines 13 to 27 months after vaccination.
Sejda J; Helcl J; Strauss J; Zdrazílek J; Mírovský J
J Hyg Epidemiol Microbiol Immunol; 1968; 12(2):187-91. PubMed ID: 5752748
[No Abstract] [Full Text] [Related]
34. Immunogenicity of aerosol measles vaccine given as the primary measles immunization to nine-month-old Mexican children.
Wong-Chew RM; Islas-Romero R; García-García Mde L; Beeler JA; Audet S; Santos-Preciado JI; Gans H; Lew-Yasukawa L; Maldonado YA; Arvin AM; Valdespino-Gómez JL
Vaccine; 2006 Jan; 24(5):683-90. PubMed ID: 16154241
[TBL] [Abstract][Full Text] [Related]
35. [Rubeola vaccination. Serological and clinical studies of the "Cendehill strain" live vaccine].
Zellweger U; Kayser FH; Hitzig WH
Dtsch Med Wochenschr; 1969 Mar; 94(10):461-5. PubMed ID: 5764887
[No Abstract] [Full Text] [Related]
36. Measles immunity after revaccination: results in children vaccinated before 10 months of age.
Linnemann CC; Dine MS; Roselle GA; Askey PA
Pediatrics; 1982 Mar; 69(3):332-5. PubMed ID: 7063289
[TBL] [Abstract][Full Text] [Related]
37. [Materials on the serologic study of children inoculated with live measles vaccine].
Kaplan AS; Zubov AK
Zh Mikrobiol Epidemiol Immunobiol; 1977 Dec; (12):64-70. PubMed ID: 602545
[TBL] [Abstract][Full Text] [Related]
38. Measles vaccination.
Norrby EC
Bull Pan Am Health Organ; 1976; 10(3):196-7. PubMed ID: 1000095
[TBL] [Abstract][Full Text] [Related]
39. Sensitizing versus immunizing properties of inactivated measles vaccine.
Wilson S; Aprile MA
Prog Immunobiol Stand; 1970; 4():657-60. PubMed ID: 4991597
[No Abstract] [Full Text] [Related]
40. Combined live measles-mumps virus vaccine.
Weibel RE; Villarejos VM; Hernández G; Stokes J; Buynak EB; Hilleman MR
Arch Dis Child; 1973 Jul; 48(7):532-6. PubMed ID: 4719108
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
